Skip to content

Clinical trials

Colonic Neoplasms trials in Italy with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Phase: Not applicable Country / region: Italy Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20102
20111
20152
20171
20193
20202
20213
20223
20234
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Unknown status5
Active, not recruiting3
Not yet recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Poliambulanza Istituto Ospedaliero2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Istituto Clinico Humanitas2
University of Roma La Sapienza2
University of Turin, Italy2
Azienda Ospedaliero-Universitaria Careggi1
Azienda Ospedaliero-Universitaria di Modena1
Catholic University of the Sacred Heart1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione del Piemonte per l'Oncologia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms28
Colorectal Neoplasms4
Anastomotic Leak3
Rectal Neoplasms3
Breast Neoplasms2
Colonic Polyps2
Esophageal Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Bile Duct Neoplasms1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.